Evaluation of Automatic Class III Designation (De Novo) Summaries - Invitae Common Hereditary Cancers Panel (DEN210011)

https://www.fda.gov/about-fda/cdrh-transparency/evaluation-automatic-class-iii-designation-de-novo-summaries?utm_medium=email&utm_source=govdelivery